Background WHO reported that 5.5 million people died in the world because of COVID-19.
One of the efforts to mitigate the pandemic is administrating the vaccines globally. Objective …

Objective To provide recommendations for overcoming the challenges associated with the
generation and use of real-world evidence (RWE) in regulatory approvals, health technology …

The available evidence on relative effectiveness and risks of new health technologies is
often limited at the time of health technology assessment (HTA). Additionally, a wide variety …

Ideally, all health policy decisions should involve the use of HTA processes and methods
which offer quality, context-specific and locally relevant evidence. However, where the 'gold …

Even though randomized controlled clinical trials (RCTs) have been accepted as the gold
standard for official assessment of novel interventions, there is a substantial gap between …

The CanREValue Collaboration established the Reassessment & Uptake Working Group to
develop a preliminary process to reassess funded cancer drugs in Canada. A simulated …

All health systems must set priorities. Evidence-informed priority-setting (EIPS) is a specific
form of systematic priority-setting which involves explicit consideration of evidence to …

Background Due to limited access to primary percutaneous coronary intervention for the
management of ST-segment elevation myocardial infarction (STEMI) in low-to-middle …

Objective: This systematic review aimed to assess the current use and acceptance of real-
world data (RWD) and real-world evidence (RWE) in health technology assessment (HTA) …

Background The use of real-world data (RWD) warehouses for research in Asia is on the
rise, but current trends remain largely unexplored. Given the varied economic and health …